drugset / Trial / NCT01839149
TI-001 (Intranasal Oxytocin) for Treatment of High Frequency Episodic Migraine and Chronic Migraine
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study evaluates the use of oxytocin, given as a nasal spray, for treatment of high frequency episodic migraine and chronic migraine.
Timeline
- Start
- 2013-05
- Primary completion
- 2015-10
- Completion
- 2016-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxytocin | Peptide | — | Intranasal |
Indications
No indication recorded.